Follow
Sprint Bioscience AB
Nasdaq First North Sweden (Sweden)
Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.
Sector:
HEALTH CARE
Sector:
TECHNOLOGY
New issue
Price
5.50 SEK
Subscription period
02 Jun - 16 Jun 2020
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
SPRINT
SE0006343745
Nasdaq First North Sweden
Sweden (SE)
Details of share in Sprint Bioscience AB with ticker SPRINT
Status
Active
Order book id
Amount of instruments
12 342 560
Par value
0.1000
Market cap
Currency
SEK
Segment
First North Premier
First trading date
07 Nov 2014
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
15.00 SEK
75.6M SEK
06 Oct - 24 Oct 2014
IPO in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
06 Oct - 24 Oct 2014
Subscription price
15.00 SEK
Price per share
15.00 SEK
Target to raise
22 500 000 SEK
Types
Share issue
Pre-money valuation
75 600 000 SEK
Subscription block size
Minimum subscription
400
Record date
Offer status
Closed
Listing status
Listed
First trading date
07 Nov 2014
Issue terms
Open to the public.
Comments for offer & related information
First day of trading on First Nort is scheduled for November 7, 2014.
The company issues 1 500 000 shares.
Type
Price
Pre-money valuation
Time
Files
New issue
37.00 SEK
242M SEK
15 Mar 2016
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription date
15 Mar 2016
Subscription price
Price per share
37.00 SEK
Target to raise
19 200 000 SEK
Types
Share issue
Pre-money valuation
242 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to a limited group of institutional and private investors, through bookbuilding.
Comments for offer & related information
The company issues 518 200 shares. The subscription price has been set at SEK 37 per share through a bookbuilding process, which corresponds to a discount of 6.6 per cent against the volume-weighted price of the ten most recent trading days.
Type
Price
Pre-money valuation
Time
Files
New issue
21.50 SEK
151.9M SEK
11 Sep 2017
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription date
11 Sep 2017
Subscription price
Price per share
21.50 SEK
Target to raise
11 008 000 SEK
Types
Share issue
Pre-money valuation
151 900 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to a limited circle of institutional and private investors, including Roosgruppen AB.
Comments for offer & related information
The company issues 512 000 shares. The subscription price has been set at SEK 21.50 per share through a bookbuilding process, which corresponds to a discount of just under 5% per cent against the volume weighted price of the last 10 trading days.
Type
Price
Pre-money valuation
Time
Files
New issue
15.00 SEK
114M SEK
15 Feb - 01 Mar 2018
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
15 Feb - 01 Mar 2018
Subscription price
15.00 SEK
Price per share
15.00 SEK
Target to raise
37 900 000 SEK
Types
Share issue
Pre-money valuation
114 000 000 SEK
Subscription block size
Minimum subscription
Record date
13 Feb 2018
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 1:3. Shareholders have preferential rights to subscribe for one (1) unit, consisting of one (1) share and two (2) warrants of series 2018/2019:1, for each three (3) existing shares held on the record date.
Comments for offer & related information
The rights issue is covered by subscription obligations and guarantee commitments up to a total of 100% of the initial issue proceeds.
The company issues 2 524 945 shares. Three (3) warrants of series 2018/2019: 1 entitle the holder to subscribe for one (1) new share in the Company at a subscription price per share which shall correspond to 70% of the volume weighted average price for the Company's share on Nasdaq First North Premier during the period from and with January 14, 2019 through January 25, 2019, however, a minimum of SEK 15 and a maximum of SEK 29. Subscription of shares in the Company with the support of warrants of series 2018/2019: 1 may take place during the period from 28 January 2019 to 8 February 2019.

Type
Price
Pre-money valuation
Time
Files
Exercise
17.17 SEK
28 Jan - 08 Feb 2019
Option exercise terms for SPRINT TO 2018/2019
Former ticker
SPRITN TO 1
Market
Nasdaq First North Sweden
Exercise period(s)
28 Jan - 08 Feb 2019
Exercise price range
15.00-29.00 SEK
Exercise final price
17.17 SEK
Status
Closed
Issue terms
Three (3) subscription options gives the holder the right to subscribe for 1 new share at a price that is 70 % of the volume weighted average market price during 14-25 January 2019. But no lower thatn 15 SEK and not higher than 29 SEK. Exercise period is 28 January - 8 February 2019.
Result of offer
Sprint Bioscience AB warrants in the form of the TO1 series were subscribed to 90.76 percent, which means that the company will receive approximately SEK 26.2 million before issue costs of approximately SEK 1.2 million.
Type
Price
Pre-money valuation
Time
Files
New issue
14.00 SEK
03 Oct 2019
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription date
03 Oct 2019
Subscription price
1 400.00 SEK
Price per share
14.00 SEK
Target to raise
10 010 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
100
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed issue, to a consortium led by Gerhard Dal and Råsunda Förvaltning.
Comments for offer & related information
The private placement consists of a total of 7150 Units. Each Unit consists of 100 shares of SEK 14 and 34 warrants of series 1 and 34 warrants of series 2. The warrants are issued free of charge and can provide Sprint up to SEK 7.4 million (SEK 3.5 million from TO 1 and SEK 3.9 from TO 2).
Type
Price
Pre-money valuation
Time
Files
Exercise
14.50 SEK
14 Feb - 28 Feb 2020
Option exercise terms for SPRITN TO1
Market
Nasdaq First North Sweden
Exercise period(s)
14 Feb - 28 Feb 2020
Exercise price
14.50 SEK
Status
Closed
Issue terms
Each warrant Series 1 entitles the holder to subscribe for one (1) share.
Type
Price
Pre-money valuation
Time
Files
Exercise
8.21 SEK
14 May - 28 May 2020
Option exercise terms for SPRINT TO2
Former ISIN
SPRINT TO 2
Market
Nasdaq First North Sweden
Exercise period(s)
14 May - 28 May 2020
Exercise price
8.21 SEK
Status
Closed
Issue terms
Each warrant of Series 2 entitles the holder to subscribe for one (1) share at a price corresponding to 30% discount on the volume-weighted price during the period 27 April 2020 - 8 May 2020, however, a maximum of SEK 16.
Update (11.05.2020): The Company's outstanding warrants of series TO2 2019 have exercise periods from May 14, 2020 through May 28, 2020. If the Rights Issue is carried out in accordance with the proposed schedule, a recalculated subscription price as well as a recalculated number of shares that each subscription warrants entitle to subscribe for will be applied. such subscription of shares with the support of warrants exercised at such a time that the right to participate in the Rights Issue does not arise. Such recalculation will take place in accordance with “Appendix B - Full terms for warrants of series TO2”, but will not, because of how the terms for the warrants have been designed, be made before the Rights Issue has been completed, but is expected to be done no later than week 26 and communicated soon thereafter.
Type
Price
Pre-money valuation
Time
Files
New issue
5.50 SEK
67.9M SEK
02 Jun - 16 Jun 2020
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
02 Jun - 16 Jun 2020
Subscription price
16.50 SEK
Price per share
5.50 SEK
Target to raise
48 500 000 SEK
Types
Share issue
Pre-money valuation
67 900 000 SEK
Subscription block size
Minimum subscription
Record date
29 May 2020
Offer status
Upcoming
Listing status
Listed
Issue terms
Rights issue. Every seven (7) existing shares held on the record date entitles the holder to subscribe for five (5) new shares.
Comments for offer & related information
The company issues 2 939 400 units, i.e. 8 818 200 shares and 2 939 400 warrants of serie TO4. The rights issue is secured at 80 percent through subscription commitments from existing shareholders and guarantee commitments from non-shareholders. Each unit is intended to consist of three (3) shares and one (1) free subscription option 2020/2021 TO4.
Type
Ticker
ISIN
Market
OPTION
SPRITN TO 4
SE0014428199
Nasdaq First North Sweden
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRITN TO 4
Status
Inactive
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
The warrants are intended to be issued without consideration and each warrants are intended to give the right to subscribe for one (1) share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
8.25 SEK
15 Feb - 14 Mar 2021
Option exercise terms for SPRITN TO 4
Market
Nasdaq First North Sweden
Exercise period(s)
15 Feb - 14 Mar 2021
Exercise price
8.25 SEK
Status
Upcoming
Issue terms
The warrants are intended to be issued without consideration and each warrants are intended to give the right to subscribe for one (1) share in the Company.
Type
Ticker
ISIN
Market
SHARE
SPRINT
SE0006343745
Nasdaq First North Sweden
Sweden (SE)
Details of share in Sprint Bioscience AB with ticker SPRINT
Status
Active
Order book id
Amount of instruments
12 342 560
Par value
0.1000
Market cap
Currency
SEK
Segment
First North Premier
First trading date
07 Nov 2014
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
15.00 SEK
75.6M SEK
06 Oct - 24 Oct 2014
IPO in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
06 Oct - 24 Oct 2014
Subscription price
15.00 SEK
Price per share
15.00 SEK
Target to raise
22 500 000 SEK
Types
Share issue
Pre-money valuation
75 600 000 SEK
Subscription block size
Minimum subscription
400
Record date
Offer status
Closed
Listing status
Listed
First trading date
07 Nov 2014
Issue terms
Open to the public.
Comments for offer & related information
First day of trading on First Nort is scheduled for November 7, 2014.
The company issues 1 500 000 shares.
Type
Price
Pre-money valuation
Time
Files
New issue
37.00 SEK
242M SEK
15 Mar 2016
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription date
15 Mar 2016
Subscription price
Price per share
37.00 SEK
Target to raise
19 200 000 SEK
Types
Share issue
Pre-money valuation
242 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to a limited group of institutional and private investors, through bookbuilding.
Comments for offer & related information
The company issues 518 200 shares. The subscription price has been set at SEK 37 per share through a bookbuilding process, which corresponds to a discount of 6.6 per cent against the volume-weighted price of the ten most recent trading days.
Type
Price
Pre-money valuation
Time
Files
New issue
21.50 SEK
151.9M SEK
11 Sep 2017
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription date
11 Sep 2017
Subscription price
Price per share
21.50 SEK
Target to raise
11 008 000 SEK
Types
Share issue
Pre-money valuation
151 900 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to a limited circle of institutional and private investors, including Roosgruppen AB.
Comments for offer & related information
The company issues 512 000 shares. The subscription price has been set at SEK 21.50 per share through a bookbuilding process, which corresponds to a discount of just under 5% per cent against the volume weighted price of the last 10 trading days.
Type
Price
Pre-money valuation
Time
Files
New issue
15.00 SEK
114M SEK
15 Feb - 01 Mar 2018
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
15 Feb - 01 Mar 2018
Subscription price
15.00 SEK
Price per share
15.00 SEK
Target to raise
37 900 000 SEK
Types
Share issue
Pre-money valuation
114 000 000 SEK
Subscription block size
Minimum subscription
Record date
13 Feb 2018
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 1:3. Shareholders have preferential rights to subscribe for one (1) unit, consisting of one (1) share and two (2) warrants of series 2018/2019:1, for each three (3) existing shares held on the record date.
Comments for offer & related information
The rights issue is covered by subscription obligations and guarantee commitments up to a total of 100% of the initial issue proceeds.
The company issues 2 524 945 shares. Three (3) warrants of series 2018/2019: 1 entitle the holder to subscribe for one (1) new share in the Company at a subscription price per share which shall correspond to 70% of the volume weighted average price for the Company's share on Nasdaq First North Premier during the period from and with January 14, 2019 through January 25, 2019, however, a minimum of SEK 15 and a maximum of SEK 29. Subscription of shares in the Company with the support of warrants of series 2018/2019: 1 may take place during the period from 28 January 2019 to 8 February 2019.

Type
Price
Pre-money valuation
Time
Files
New issue
14.00 SEK
03 Oct 2019
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription date
03 Oct 2019
Subscription price
1 400.00 SEK
Price per share
14.00 SEK
Target to raise
10 010 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
100
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed issue, to a consortium led by Gerhard Dal and Råsunda Förvaltning.
Comments for offer & related information
The private placement consists of a total of 7150 Units. Each Unit consists of 100 shares of SEK 14 and 34 warrants of series 1 and 34 warrants of series 2. The warrants are issued free of charge and can provide Sprint up to SEK 7.4 million (SEK 3.5 million from TO 1 and SEK 3.9 from TO 2).
Type
Price
Pre-money valuation
Time
Files
New issue
5.50 SEK
67.9M SEK
02 Jun - 16 Jun 2020
Share issue in Sprint Bioscience AB
Market
Nasdaq First North Sweden
Subscription period
02 Jun - 16 Jun 2020
Subscription price
16.50 SEK
Price per share
5.50 SEK
Target to raise
48 500 000 SEK
Types
Share issue
Pre-money valuation
67 900 000 SEK
Subscription block size
Minimum subscription
Record date
29 May 2020
Offer status
Upcoming
Listing status
Listed
Issue terms
Rights issue. Every seven (7) existing shares held on the record date entitles the holder to subscribe for five (5) new shares.
Comments for offer & related information
The company issues 2 939 400 units, i.e. 8 818 200 shares and 2 939 400 warrants of serie TO4. The rights issue is secured at 80 percent through subscription commitments from existing shareholders and guarantee commitments from non-shareholders. Each unit is intended to consist of three (3) shares and one (1) free subscription option 2020/2021 TO4.
Type
Ticker
ISIN
Market
OPTION
SPRINT TO 2018/2019
SE0010833178
Nasdaq First North Sweden
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO 2018/2019
Status
Archived
Order book id
153717
Amount of instruments
Market cap
Currency
SEK
Segment
First North Premier
Trading period
12 Apr 2018 - 06 Feb 2019
Terms
Three (3) subscription options gives the holder the right to subscribe for 1 new share at a price that is 70 % of the volume weighted average market price during 14-25 January 2019. But no lower thatn 15 SEK and not higher than 29 SEK. Exercise period is 28 January - 8 February 2019.
Type
Price
Pre-money valuation
Time
Files
Exercise
17.17 SEK
28 Jan - 08 Feb 2019
Option exercise terms for SPRINT TO 2018/2019
Former ticker
SPRITN TO 1
Market
Nasdaq First North Sweden
Exercise period(s)
28 Jan - 08 Feb 2019
Exercise price range
15.00-29.00 SEK
Exercise final price
17.17 SEK
Status
Closed
Issue terms
Three (3) subscription options gives the holder the right to subscribe for 1 new share at a price that is 70 % of the volume weighted average market price during 14-25 January 2019. But no lower thatn 15 SEK and not higher than 29 SEK. Exercise period is 28 January - 8 February 2019.
Result of offer
Sprint Bioscience AB warrants in the form of the TO1 series were subscribed to 90.76 percent, which means that the company will receive approximately SEK 26.2 million before issue costs of approximately SEK 1.2 million.
Type
Ticker
ISIN
Market
OPTION
SPRITN TO1
SE0013282050
Nasdaq First North Sweden
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRITN TO1
Status
Archived
Order book id
183922
Amount of instruments
830 540
Market cap
Currency
SEK
Segment
First North Premier
Trading period
14 Feb 2020 - 26 Feb 2020
Terms
Each warrant Series 1 entitles the holder to subscribe for one (1) share.
Type
Price
Pre-money valuation
Time
Files
Exercise
14.50 SEK
14 Feb - 28 Feb 2020
Option exercise terms for SPRITN TO1
Market
Nasdaq First North Sweden
Exercise period(s)
14 Feb - 28 Feb 2020
Exercise price
14.50 SEK
Status
Closed
Issue terms
Each warrant Series 1 entitles the holder to subscribe for one (1) share.
Type
Ticker
ISIN
Market
OPTION
SPRINT TO2
SE0013282068
Nasdaq First North Sweden
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO2
Status
Archived
Order book id
183923
Amount of instruments
830 540
Market cap
Currency
SEK
Segment
First North Premier
Trading period
14 Feb 2020 - 26 May 2020
Terms
Each warrant of Series 2 entitles the holder to subscribe for one (1) share at a price corresponding to 30% discount on the volume-weighted price during the period 27 April 2020 - 8 May 2020, however, a maximum of SEK 16.
Update (11.05.2020): The Company's outstanding warrants of series TO2 2019 have exercise periods from May 14, 2020 through May 28, 2020. If the Rights Issue is carried out in accordance with the proposed schedule, a recalculated subscription price as well as a recalculated number of shares that each subscription warrants entitle to subscribe for will be applied. such subscription of shares with the support of warrants exercised at such a time that the right to participate in the Rights Issue does not arise. Such recalculation will take place in accordance with “Appendix B - Full terms for warrants of series TO2”, but will not, because of how the terms for the warrants have been designed, be made before the Rights Issue has been completed, but is expected to be done no later than week 26 and communicated soon thereafter.
Type
Price
Pre-money valuation
Time
Files
Exercise
8.21 SEK
14 May - 28 May 2020
Option exercise terms for SPRINT TO2
Former ISIN
SPRINT TO 2
Market
Nasdaq First North Sweden
Exercise period(s)
14 May - 28 May 2020
Exercise price
8.21 SEK
Status
Closed
Issue terms
Each warrant of Series 2 entitles the holder to subscribe for one (1) share at a price corresponding to 30% discount on the volume-weighted price during the period 27 April 2020 - 8 May 2020, however, a maximum of SEK 16.
Update (11.05.2020): The Company's outstanding warrants of series TO2 2019 have exercise periods from May 14, 2020 through May 28, 2020. If the Rights Issue is carried out in accordance with the proposed schedule, a recalculated subscription price as well as a recalculated number of shares that each subscription warrants entitle to subscribe for will be applied. such subscription of shares with the support of warrants exercised at such a time that the right to participate in the Rights Issue does not arise. Such recalculation will take place in accordance with “Appendix B - Full terms for warrants of series TO2”, but will not, because of how the terms for the warrants have been designed, be made before the Rights Issue has been completed, but is expected to be done no later than week 26 and communicated soon thereafter.
Type
Ticker
ISIN
Market
OPTION
SPRITN TO 4
SE0014428199
Nasdaq First North Sweden
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRITN TO 4
Status
Inactive
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
The warrants are intended to be issued without consideration and each warrants are intended to give the right to subscribe for one (1) share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
8.25 SEK
15 Feb - 14 Mar 2021
Option exercise terms for SPRITN TO 4
Market
Nasdaq First North Sweden
Exercise period(s)
15 Feb - 14 Mar 2021
Exercise price
8.25 SEK
Status
Upcoming
Issue terms
The warrants are intended to be issued without consideration and each warrants are intended to give the right to subscribe for one (1) share in the Company.
People
Number of Employees
33 people
Anders Åberg
CEO
Rune Nordlander
Chairman of the board
Rune Nordlander
Board member
Karin Meyer
Board member
Charlotta Liljebris
Board member
Ingemar Kihlström
Board member
Company Details
Sector
HEALTH CARE, TECHNOLOGY

Address
C/O Novum
Zip code
141 57
City/district
Huddinge
Country
Sweden (SE)
Registration number
556789-7557
LEI code
5493006ED74WIIQOKC56
First trade date
07 Nov 2014
Registration date
28 Sep 2009
Short name
Sprint Bioscience

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date